Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Boeing Reaches Tentative Settlement With Canadian Victim’s Family in 737 MAX Crash Lawsuits 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
One Percent Rule Checklist For Safer Forex Trading Risk 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions 
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
MALVERN, Pa., April 09, 2017 -- BioTelemetry, Inc. (NASDAQ:BEAT) will hold an investor call tomorrow, April 10, 2017 at 9:00 AM Eastern Time to discuss the recently announced transaction agreement for BioTelemetry to launch a tender offer to acquire LifeWatch AG
The broadcast will be available through the investor information section of the BioTelemetry website: www.gobio.com. If you are unable to participate during the live webcast, an archive will be available on our website for two weeks.
About BioTelemetry
BioTelemetry, Inc., formerly known as CardioNet, Inc., is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The Company currently provides cardiac monitoring services, original equipment manufacturing with a primary focus on cardiac monitoring devices and centralized cardiac core laboratory services. More information can be found at www.gobio.com.
Contact: BioTelemetry, Inc. Heather C. Getz Investor Relations 800-908-7103 [email protected]
